Real world data

#AI #Clinical development #Clinical trial #Norstella #Real world data

How AI has revolutionised clinical development

The latest episode of the DDW ‘In Conversation With’ series is available to listen to below. This week, Bruno Quinney speaks to Suzanne Caruso, President of Strategic Intelligence and Clinical & Regulatory at Norstella. Norstella supports drug developers looking to take their treatments from pipeline to patients, finding solutions to complexities… Read More

#Featured Podcasts #Podcasts

#ABPI #Clinical trial design #Clinical trials #Real world data

NHS health data should be used for clinical trial recruitment, says ABPI

The UK has an opportunity to enhance its global competitiveness in the delivery of industry clinical trials by harnessing NHS health data to more efficiently recruit patients, according to a new report from the ABPI.  Following a period of decline, the number of industry clinical trials in… Read More

#News

CAR-T therapy
#Blood cancer #CAR-T #Haematology #Kite Pharma #Oncology #Real world data

Real-world evidence supports use of CAR-T therapies in blood cancers

Real-world evidence from the French DESCAR-T registry has shown an overall response rate (ORR) of 76.9% and complete response rate (CR) of 57.7% in large B-cell lymphoma (LBCL) patients treated with axicabtagene ciloleucel (Yescarta). Axicabtagene ciloleucel was also associated with less than 5% grade ≥3 cytokine… Read More

#Cancer Research #News #Trending News

#CorEvitas #Mergers and acquisitions #Real world data #Thermo Fisher Scientific

Thermo Fisher Scientific acquires real-world evidence provider

Thermo Fisher Scientific has completed its acquisition of CorEvitas, a provider of real-world evidence for approved medical treatments and therapies, for $912.5 million. Real-world evidence is a high growth market segment as pharmaceutical and biotechnology customers, as well as regulating bodies, are increasingly looking to monitor… Read More

#Business & Investment #News

Female scientist
#AI / data analytics / healthtech / informatics #BC Platforms #Rare disease #Real world data

Harnessing real-world data for rare and orphan disease research

This paid-for advertorial by BC Platforms appeared in DDW Volume 24 – Issue 3, Summer 2023 The use of real-world data (RWD) is demonstrating significant potential to enhance rare and orphan disease clinical research and development. By incorporating data from sources such as electronic health records, medical claims, patient… Read More

#Exclusive Content

Kidneys
#AstraZeneca #Cardiovascular disease #Chronic kidney disease (CKD) #Heart failure #Real world data

RWE shows risk of cutting RAASi medication in cardiorenal patients

A real-world evidence (RWE) study has shown the negative consequences of reducing or discontinuing renin-angiotensin-aldosterone system inhibitor (RAASi) medication in patients experiencing hyperkalaemia (HK). One analysis from AstraZeneca’s ZORA study showed that discontinuation of RAASi treatment following a HK episode in cardiorenal patients with chronic kidney… Read More

#News

#Cancer research #Collaboration #Data security #Flatiron Health #Lifebit #Oncology #Partnership #Real world data

Partnership hopes to accelerate cancer data research

Lifebit and Flatiron Health have announced a multi-year strategic partnership with the aim of improving scientific discoveries by learning from the experience of  cancer patients. Health data generated by hospitals, healthcare providers, research organisations and clinical trials hold the potential to advance research and innovation, improve… Read More

#Business & Investment #News

Real world data
#AI / data analytics / healthtech / informatics #BC Platforms #Clinical trials #Real world data #Regulatory

Enabling regulatory approval submissions with external control arms

This paid-for advertorial by BC Platforms appeared in DDW Volume 24 – Issue 2, Spring 2023 BC Platforms’ Global Data Partner Network provides patient-level, longitudinal, and geographically diverse real-world data and real-world evidence for use as external control arms in randomised human clinical trials, which can… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Life sciences #Pistoia Alliance #R&D #Real world data #Technology

Social media project will drive patient centricity in drug development  

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has launched a new Community of Experts (CoE) with the aim of harnessing real-world data (RWD) from social media. The organisation is calling on technology companies, data scientists and RWD experts to join… Read More

#News